Latest Financial Health News

Pengana International Equities Limited has announced an on-market buy-back of up to 25.7 million ordinary shares, signaling a strategic capital management move without requiring shareholder approval.

Computershare Limited has announced an ordinary dividend of AUD 0.48 per share for the half-year ending June 2025, alongside a confirmed Dividend Reinvestment Plan price of AUD 37.64.

PolarX Limited's trading suspension has been lifted immediately following its announcement of a new capital raising, signaling renewed market activity for the mining explorer.

Rewardle Holdings reported a modest revenue increase for FY25 but saw its loss more than double, driven by investments in AI-powered MedTech associate CloudHolter and expanded platform initiatives.

Wesfarmers Limited has updated its dividend details, confirming a fully franked ordinary dividend of AUD 1.11 per share payable on 7 October 2025, with shareholders able to receive payments in AUD, NZD, or GBP.

Tasmea Limited has firmly denied recent media speculation about potential block trades by its executive directors, reaffirming their strong shareholding and commitment to growth. The company is focused on organic expansion and acquisitions to secure ASX 300 inclusion next year without raising new capital.

OM Holdings reported steady revenue of US$309.3 million in 1H 2025 despite a sharp EBITDA decline and net loss, while maintaining a strong cash position and advancing sustainability goals.

Ryder Capital Limited reports a striking 12.75% preliminary gain in its investment portfolio for August 2025, lifting its pre-tax net tangible assets per share to $1.964 before dividend payout.

Clime Investment Management has reported a strong FY25 profit turnaround, posting $2.1 million pretax and amortisation profit and declaring a fully franked dividend. The company outlines ambitious growth and margin targets for FY26 amid strategic restructuring and technology investments.

Pro-Pac Packaging is progressing a strategic review involving potential asset sales and liquidity support, with ASX trading suspension imminent pending financial disclosures.

InFocus Group Holdings reported a 5.3% revenue increase for FY2025 but also a nearly 20% rise in net losses, alongside a sharp drop in net tangible assets per share.

Cardiex Limited reported a 10% revenue increase in FY25, driven by new product launches and significant cost reductions, positioning the company for growth in FY26 with strong backing from C2 Ventures.